Dr. Takeshima@Web

       

 

 

 

 

             

 

 

 

 英文原著 1) Takeshima T , Sakai F, Hirata K, Imai N, Matsumori Y, Yoshida R, Peng C, Cheng S, Mikol DD.  Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double-blind, placebo-controlled study. Headache 2021;61(6): 927-935. https://www.ncbi.nlm.nih.gov/pubmed/34153117 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361926/pdf/HEAD-61-927.pdf   2)  Hirata K, Sakai F, Takeshima T , Imai N, Matsumori Y, Yoshida R, Numachi Y, Peng C, Mikol DD, Cheng S. Efficacy and safety of erenumab in Japanese migraine patients with prior preventive treatment failure or concomitant preventive treatment: subgroup analyses of a phase 3, randomized trial. J Headache Pain. 2021;22(1): 110. https://www.ncbi.nlm.nih.gov/pubmed/34537006 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449906/pdf/10194_2021_Article_1313.pdf 3)  Hirata K, Ueda K, Komori M, Zagar AJ, Selzler KJ, Nelson AM, Han Y, Jaffe DH, Matsumori Y, Takeshima T . Comprehensive popu